Literature DB >> 2525056

Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis.

R Morgan1, S D Smith, B K Hecht, V Christy, J D Mellentin, R Warnke, M L Cleary.   

Abstract

We report the molecular, cytogenetic, and immunologic characterization of three hematologic malignancies that contained characteristic t(2;5) chromosomal translocations. The clinicopathologic features in all three cases fit the disease spectrum of so-called malignant histiocytosis (MH). All cases expressed activation antigens including Ki-1 (CD 30), but no lineage-restricted pattern of cellular antigen expression was observed. Cell lines SUP-M2 and SU-DHL-1 established from two of the cases showed rearranged beta T-cell receptor (beta TCR) genes nonproductive of full-length beta TCR mRNA and therefore not helpful in unequivocal establishment of lineage derivation. The common cytogenetic feature was a reciprocal translocation between chromosomes 2 and 5, involving bands 2p23 and 5q35 near the reported chromosomal locations of the N-myc and c-fms genes, respectively. Normal-sized and truncated c-fms RNAs were observed in both cell lines, whereas no N-myc transcripts were detected. Sequence analysis of the truncated fms RNA showed that it consisted of the 3' half of the c-fms mRNA, but its derivation was not the result of a structural alteration of the c-fms gene. Our studies show that the t(2;5) does not involve the N-myc and c-fms protooncogenes and that this cytogenetic abnormality may be characteristic of a subset of primitive malignancies with an indeterminate lineage but with clinicopathologic features of so-called MH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525056

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Essential role of TAK1 in regulating mantle cell lymphoma survival.

Authors:  Daniela Buglio; Sangeetha Palakurthi; Kate Byth; Francisco Vega; Dorin Toader; Jamal Saeh; Sattva S Neelapu; Anas Younes
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

2.  Influenza A and the virus associated haemophagocytic syndrome: cluster of three cases in children with acute leukaemia.

Authors:  M N Potter; A B Foot; A Oakhill
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

Review 3.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

4.  Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.

Authors:  S M Hsu; Y S Ho; P L Hsu
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  A novel role for IL-22R1 as a driver of inflammation.

Authors:  Ram Savan; Adelle P McFarland; Della A Reynolds; Lionel Feigenbaum; Karthika Ramakrishnan; Megan Karwan; Hidekazu Shirota; Dennis M Klinman; Kieron Dunleavy; Stefania Pittaluga; Stephen K Anderson; Raymond P Donnelly; Wyndham H Wilson; Howard A Young
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

6.  Sinus histiocytosis with massive lymphadenopathy: immunological, cytogenetic and molecular studies.

Authors:  S Sacchi; T Artusi; L Selleri; P Temperani; P Zucchini; A Vecchi; G Emilia; U Torelli
Journal:  Blut       Date:  1990-06

7.  Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas.

Authors:  Roberto Piva; Roberto Chiarle; Andrea D Manazza; Riccardo Taulli; William Simmons; Chiara Ambrogio; Valentina D'Escamard; Elisa Pellegrino; Carola Ponzetto; Giorgio Palestro; Giorgio Inghirami
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

8.  Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors.

Authors:  Annunziata Gloghini; Daniela Buglio; Noor M Khaskhely; Georgios Georgakis; Robert Z Orlowski; Sattva S Neelapu; Antonino Carbone; Anas Younes
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

9.  Malignant histiocytosis. A phenotypic and genotypic investigation.

Authors:  G Cattoretti; A Villa; P Vezzoni; R Giardini; L Lombardi; F Rilke
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

10.  Synergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126.

Authors:  M Ito; N Zhao; Z Zeng; C C Chang; Y Zu
Journal:  Cancer Gene Ther       Date:  2010-05-07       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.